NCT07672366 Person-Centered Occupational Therapy in Older Adults
| NCT ID | NCT07672366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Atlas University |
| Condition | Older Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 154 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 154 participants in total. It began in 2026-04-15 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was designed to investigate the effects of a person-centered occupational therapy approach on quality of life and occupational balance among community-dwelling older adults. The study is a randomized controlled trial utilizing semi-structured interviews and self-report measures. The target population consists of individuals aged 65 years and older living in Istanbul. The sample size was calculated using G\*Power software, indicating a minimum of 77 participants per group, for a total of 154 participants. Considering potential attrition, a total sample of 170 participants is planned. Data will be collected using a Sociodemographic Information Form, the Mini-Mental State Examination (MMSE), the Occupational Performance History Interview-II (OPHI-II), Goal Attainment Scaling (GAS), the World Health Organization Quality of Life Instrument-Older Adults Module (WHOQOL-OLD), and the Activity-Role Balance Questionnaire. Cognitive eligibility will be assessed using the MMSE, and individuals scoring 24 or higher will be included in the study. Through the OPHI-II, participants' life histories, roles, habits, and experiences related to daily activities will be explored, and individualized goals will be identified based on the information obtained. These goals will subsequently be structured using the Goal Attainment Scaling method. Participants will be randomly allocated to either the intervention group or the control group. Participants in the intervention group will receive person-centered occupational therapy sessions delivered via telerehabilitation, while those in the control group will continue their usual daily routines without additional support. At the end of the study, outcomes related to quality of life and occupational balance will be compared between groups. The findings are expected to provide evidence regarding the role of a person-centered occupational therapy approach in supporting participation in daily life activities among older adults.
Eligibility Criteria
Inclusion Criteria: * Aged 65 years or older. * Living independently in the community. * Scoring 24 or higher on the Mini-Mental State Examination (MMSE). * Having sufficient communication abilities to participate in interviews and assessments. * Willing to participate and provide informed consent. Exclusion Criteria: * Having an acute medical or psychiatric condition that may prevent participation in the study. * Having communication difficulties that interfere with participation despite the use of assistive devices (e.g., hearing aids, glasses).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07672366 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Older Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07672366 currently recruiting?
Yes, NCT07672366 is actively recruiting participants. Contact the research team at zcorakci@gmail.com for enrollment information.
Where is the NCT07672366 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07672366 clinical trial?
NCT07672366 is sponsored by Atlas University. The trial plans to enroll 154 participants.